Lorlatinib

Lorlatinib


Lorlatinib (PF-06463922) is a potent, brain-penetrant oral ATP-competitive ALK/ROS1 inhibitor (sub-nanomolar Ki) that overcomes resistance mutants to disrupt oncogenic signaling and suppress tumor growth in ALK/ROS1-driven cancers.

Molecular structure of the compound BP-44027
    • Unit
    • Price
    • Qty
    • 100 MG
    • $130.00
    • 250 MG
    • $250.00
    • 500 MG
    • $430.00
    • 1 G
    • $650.00

Usually ships within 24 hours.


Would you like to inquire about custom quantity?
Inquire